Aytu Biopharma (AYTU) Enterprise Value (2011 - 2026)
Aytu Biopharma (AYTU) reported Enterprise Value of -$26.7 million for Q1 2026, down 47.0% year-over-year from -$50.4 million in Q1 2025, and up 11.02% quarter-over-quarter from -$30.0 million in Q4 2025.
Aytu Biopharma (AYTU) Enterprise Value (2011 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 16 years of Enterprise Value data on file, last reported at -$26.7 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$26.7 million, down 47.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$26.7 million (down 47.0% YoY), and the FY2025 annual result was -$31.0 million, down 54.71% from the prior year.
- Enterprise Value improved to -$26.7 million in Q1 2026 per AYTU's latest filing, from -$30.0 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$18.2 million in Q1 2025 and troughed at -$32.6 million in Q3 2025.
- A 5-year average of -$23.0 million and a median of -$20.1 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value surged 61.4% in 2022, then slumped 62.27% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$19.5 million in 2022, then retreated by 0.14% to -$19.5 million in 2023, then fell by 4.45% to -$20.4 million in 2024, then plunged by 47.2% to -$30.0 million in 2025, then grew by 11.02% to -$26.7 million in 2026.
- Business Quant data shows AYTU's Enterprise Value at -$26.7 million in Q1 2026, -$30.0 million in Q4 2025, and -$32.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -498.58 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -750.88 Mn |
| 10 | Aytu Biopharma | 24.18 Mn | -2.54 Mn | 7.60 Mn | -26.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.72 Mn |
| Dec 31, 2025 | -30.03 Mn |
| Sep 30, 2025 | -32.63 Mn |
| Jun 30, 2025 | -30.95 Mn |
| Mar 31, 2025 | -18.17 Mn |
| Dec 31, 2024 | -20.40 Mn |
| Sep 30, 2024 | -20.11 Mn |
| Jun 30, 2024 | -20.01 Mn |
| Mar 31, 2024 | -19.76 Mn |
| Dec 31, 2023 | -19.53 Mn |
| Sep 30, 2023 | -19.96 Mn |
| Jun 30, 2023 | -22.99 Mn |
| Mar 31, 2023 | -19.18 Mn |
| Dec 31, 2022 | -19.50 Mn |
| Sep 30, 2022 | -23.81 Mn |
| Jun 30, 2022 | -19.36 Mn |
| Mar 31, 2022 | -27.61 Mn |
| Dec 31, 2021 | -35.28 Mn |
| Sep 30, 2021 | -40.56 Mn |
| Jun 30, 2021 | -50.15 Mn |